These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8827714)

  • 1. The MDM2 oncoprotein binds specifically to RNA through its RING finger domain.
    Elenbaas B; Dobbelstein M; Roth J; Shenk T; Levine AJ
    Mol Med; 1996 Jul; 2(4):439-51. PubMed ID: 8827714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes.
    Marechal V; Elenbaas B; Piette J; Nicolas JC; Levine AJ
    Mol Cell Biol; 1994 Nov; 14(11):7414-20. PubMed ID: 7935455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal and RNA binding properties of the hdm2 RING finger domain.
    Lai Z; Freedman DA; Levine AJ; McLendon GL
    Biochemistry; 1998 Dec; 37(48):7005-15. PubMed ID: 9836595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
    Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
    Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of the RING finger domain of MDM2 to cell cycle progression.
    Argentini M; Barboule N; Wasylyk B
    Oncogene; 2000 Aug; 19(34):3849-57. PubMed ID: 10951578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor suppressor p53 and the oncoprotein simian virus 40 T antigen bind to overlapping domains on the MDM2 protein.
    Brown DR; Deb S; Muñoz RM; Subler MA; Deb SP
    Mol Cell Biol; 1993 Nov; 13(11):6849-57. PubMed ID: 8413278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservation of structural domains and biochemical activities of the MDM2 protein from Xenopus laevis.
    Marechal V; Elenbaas B; Taneyhill L; Piette J; Mechali M; Nicolas JC; Levine AJ; Moreau J
    Oncogene; 1997 Mar; 14(12):1427-33. PubMed ID: 9136986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
    Ghosh M; Huang K; Berberich SJ
    Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway.
    Horn HF; Vousden KH
    Oncogene; 2008 Oct; 27(44):5774-84. PubMed ID: 18560357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human MDM2 oncoprotein shows sequence composition selectivity for binding to both RNA and DNA.
    Challen C; Anderson JJ; Chrzanowska-Lightowlers ZM; Lightowlers RN; Lunec J
    Int J Oncol; 2012 Mar; 40(3):851-9. PubMed ID: 22108807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a minimal domain of 5 S ribosomal RNA sufficient for high affinity interactions with the RNA-specific zinc fingers of transcription factor IIIA.
    Neely LS; Lee BM; Xu J; Wright PE; Gottesfeld JM
    J Mol Biol; 1999 Aug; 291(3):549-60. PubMed ID: 10448036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase.
    Honda R; Yasuda H
    Oncogene; 2000 Mar; 19(11):1473-6. PubMed ID: 10723139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoter.
    Léveillard T; Wasylyk B
    J Biol Chem; 1997 Dec; 272(49):30651-61. PubMed ID: 9388200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal and RNA binding properties of the hdm2 RING finger domain.
    Lai Z; Freedman DA; Levine AJ; McLendon GL
    Biochemistry; 1998 Dec; 37(48):17005-15. PubMed ID: 9882094
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation.
    Zhang Q; Xiao H; Chai SC; Hoang QQ; Lu H
    J Biol Chem; 2011 Nov; 286(44):38264-38274. PubMed ID: 21903592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer.
    Sigalas I; Calvert AH; Anderson JJ; Neal DE; Lunec J
    Nat Med; 1996 Aug; 2(8):912-7. PubMed ID: 8705862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of individual amino acids to the 5S RNA binding activity of the Xenopus zinc finger protein p43.
    Bhatia SS; Weiss TC; Romaniuk PJ
    Biochemistry; 2008 Aug; 47(32):8398-405. PubMed ID: 18636752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of protein interaction maps by phage peptide display using MDM2 as a prototypical conformationally flexible target protein.
    Burch L; Shimizu H; Smith A; Patterson C; Hupp TR
    J Mol Biol; 2004 Mar; 337(1):129-45. PubMed ID: 15001357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point mutations and nucleotide insertions in the MDM2 zinc finger structure of human tumours.
    Schlott T; Reimer S; Jahns A; Ohlenbusch A; Ruschenburg I; Nagel H; Droese M
    J Pathol; 1997 May; 182(1):54-61. PubMed ID: 9227342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin-protein ligase activity of Hdm2 is inhibited by nucleic acids.
    Linares LK; Scheffner M
    FEBS Lett; 2003 Nov; 554(1-2):73-6. PubMed ID: 14596917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.